论文部分内容阅读
生物技术及治疗性蛋白和肽的发展为美国Middlesex Sciences公司打开了新市场。公司开发了一种专有系统以生产与含水多聚体(作为持续释放系统)结合的蛋白微粒。公司相信这项技术几乎适用于任何蛋白药物。
The development of biotech and therapeutic proteins and peptides has opened up new markets for Middlesex Sciences in the United States. The company has developed a proprietary system to produce protein particles that bind to aqueous multimers (as a sustained release system). The company believes the technology is suitable for almost any protein drug.